Recent Publications
Stevens T, Lopez R, Adler DG, Al-Haddad MA, Conway J, Dewitt JM, Forsmark CE, Kahaleh M, Lee LS, Mishra G, et al.
Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. Gastrointest Endosc.
2010;
71(3):519-526.
Vadlamudi RS, Conway JD, Kundu S, Mishra G, Baillie J, Evans JA.
Identifying patients most likely to have a common bile duct stone at ERCP after an abdominal intraoperative cholangiogram [abstract]. Gastrointest Endosc.
2010;
71(5):AB169.
Monjazeb AM, Riedlinger G, Isom S, Aklilu M, Geisinger KR, Mishra G, Levine EA, Blackstock AW.
Radiotherapy for esophageal cancer: does dose affect outcomes? [abstract]. Int J Radiat Oncol Biol Phys.
2010;
78(3 Suppl):S307.
Blackstock AW, Aklilu M, Lovato J, Degrass L, Sommer J, Howerton R, Mishra G, Levine E, McQuellon R.
Aprepitant/5HT-3 antagonist (EMEND) for the prevention of chemoradiation-induced nausea and vomiting (CRINV) in patients receiving gemcitabine/5-FU-based chemoradiation and concurrent upper abdominal radiation for pancreatic cancer [abstract]. J Clin Oncol.
2009;
27(Suppl):e20661.
Vadlamudi R, Canlas K, Kundu S, Conway J, Gadi B, Jowell P, Mishra G, Evans J.
Change in size of gastric tumors arising from the muscularis propria in patients undergoing EUS [abstract]. Am J Gastroenterol.
2009;
104(Suppl 3):S49.
Charbel S, Kimberly J, Conway J, Gilliam J, Baillie J, Mishra G.
Same-day combined EUS/ERCP to investigate biliary and pancreatic disorders: better together [abstract]. Am J Gastroenterol.
2008;
103(Suppl):S70.
Easler J, Fennimore B, Farmer M, Yacoub J, Geisinger K, Aklilu M, Blackstock W, Case D, Levine E, Mishra G.
Molecular profiling with MIB-1 correlates with microscopic evidence of residual disease in patients undergoing neoadjuvant therapy for esophageal cancer (EC) [abstract]. Gastroenterology.
2007;
132(4 Suppl 2):A854.
Kim C, Farmer MR, Yacoub J, Monjazeb A, Levine EA, Aklilu M, Geinsinger [sic] KR [Geisinger KR], Mishra G, Melin S, Blackstock AW.
Tri-modality therapy for esophageal cancer: mucinous histology is associated with decreased pathologic response rates to neoadjuvant chemoradiation therapy [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S267.
Monjazeb AM, Farmer MR, Mattern M, Mebea A, Levine EA, Geisinger KR, Mishra G, Melin S, Blackstock AW.
Patterns of failure for esophageal cancer patients optimally staged with 18-F-FDG-PET and observed after chemo-radiotherapy [abstract]. Int J Radiat Oncol Biol Phys.
2007;
69(3 Suppl):S274.
Blackstock AW, Mornex F, Partensky C, Descos L, Case LD, Melin SA, Levine EA, Mishra G, Limentani SA, Kachnic LA, et al.
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer.
2006;
95(3):260-265.
Walsh P, Gilliam J, Mishra G.
EUS guided 'pseudocystogram': an adjunct to ERCP for performing endoscopic cystgastrostomy [abstract]. Endoscopy.
2006;
38(Suppl 1):.
Walsh P, Mishra G.
CT: 'Pancreatic fullness'...EUS: 'Full of what?' [abstract]. Endoscopy.
2006;
38(Suppl 1):.
Patel NP, Cappellari JO, Mishra G.
Mastocytosis diagnosed using endoscopic ultrasound-guided fine-needle aspiration biopsy [abstract]. Arch Pathol Lab Med.
2006;
130(9):1369-1370.
Farmer MR, Yacoub J, Aklilu M, Levine EA, Geisinger K, Mishra G, Melin S, Blackstock AW.
Tri-modality therapy for esophageal cancer: hemoglobin levels are prognostic for survival but do not predict response to radiochemotherapy [abstract]. Int J Radiat Oncol Biol Phys.
2006;
66(3 Suppl):S269.
Lally BE, Butler J, Mishra G, Paskett ED, Blackstock AW.
The impact of ethnicity on survival for patients with pancreatic cancer: a SEER analysis [abstract]. In: 2006 Gastrointestinal Cancers Symposium Abstracts; 2006 Jan 26-28; San Fransciso (CA).
2006;
():Abstr 100.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.